Häfeli UO - Search Results

1

Metal nanoparticles: understanding the mechanisms behind antibacterial activity.

Slavin YN, Asnis J, Häfeli UO, Bach H. Slavin YN, et al. Among authors: hafeli uo. J Nanobiotechnology. 2017 Oct 3;15(1):65. doi: 10.1186/s12951-017-0308-z. J Nanobiotechnology. 2017. PMID: 28974225 Free PMC article. Review.

2

Human-scale navigation of magnetic microrobots in hepatic arteries.

Li N, Fei P, Tous C, Rezaei Adariani M, Hautot ML, Ouedraogo I, Hadjadj A, Dimov IP, Zhang Q, Lessard S, Nosrati Z, Ng CN, Saatchi K, Häfeli UO, Tremblay C, Kadoury S, Tang A, Martel S, Soulez G. Li N, et al. Among authors: hafeli uo. Sci Robot. 2024 Feb 14;9(87):eadh8702. doi: 10.1126/scirobotics.adh8702. Epub 2024 Feb 14. Sci Robot. 2024. PMID: 38354257

3

Effective Control of Molds Using a Combination of Nanoparticles.

Auyeung A, Casillas-Santana MÁ, Martínez-Castañón GA, Slavin YN, Zhao W, Asnis J, Häfeli UO, Bach H. Auyeung A, et al. Among authors: hafeli uo. PLoS One. 2017 Jan 25;12(1):e0169940. doi: 10.1371/journal.pone.0169940. eCollection 2017. PLoS One. 2017. PMID: 28122038 Free PMC article.

4

Rapid microwave-based method for the preparation of antimicrobial lignin-capped silver nanoparticles active against multidrug-resistant bacteria.

Pletzer D, Asnis J, Slavin YN, Hancock REW, Bach H, Saatchi K, Häfeli UO. Pletzer D, et al. Among authors: hafeli uo. Int J Pharm. 2021 Mar 1;596:120299. doi: 10.1016/j.ijpharm.2021.120299. Epub 2021 Jan 30. Int J Pharm. 2021. PMID: 33524525

5

Novel Lignin-Capped Silver Nanoparticles against Multidrug-Resistant Bacteria.

Slavin YN, Ivanova K, Hoyo J, Perelshtein I, Owen G, Haegert A, Lin YY, LeBihan S, Gedanken A, Häfeli UO, Tzanov T, Bach H. Slavin YN, et al. Among authors: hafeli uo. ACS Appl Mater Interfaces. 2021 May 19;13(19):22098-22109. doi: 10.1021/acsami.0c16921. Epub 2021 May 4. ACS Appl Mater Interfaces. 2021. PMID: 33945683 Free article.

6

A comprehensive review on the pharmacokinetics of antibiotics in interstitial fluid spaces in humans: implications on dosing and clinical pharmacokinetic monitoring.

Kiang TK, Häfeli UO, Ensom MH. Kiang TK, et al. Among authors: hafeli uo. Clin Pharmacokinet. 2014 Aug;53(8):695-730. doi: 10.1007/s40262-014-0152-3. Clin Pharmacokinet. 2014. PMID: 24972859 Review.

7

Utilization of nanoparticles as X-ray contrast agents for diagnostic imaging applications.

De La Vega JC, Häfeli UO. De La Vega JC, et al. Among authors: hafeli uo. Contrast Media Mol Imaging. 2015 Mar-Apr;10(2):81-95. doi: 10.1002/cmmi.1613. Epub 2014 Jul 7. Contrast Media Mol Imaging. 2015. PMID: 25044541 Free article. Review.

8

Cell uptake and in vitro toxicity of magnetic nanoparticles suitable for drug delivery.

Häfeli UO, Riffle JS, Harris-Shekhawat L, Carmichael-Baranauskas A, Mark F, Dailey JP, Bardenstein D. Häfeli UO, et al. Mol Pharm. 2009 Sep-Oct;6(5):1417-28. doi: 10.1021/mp900083m. Mol Pharm. 2009. PMID: 19445482

9

Focused magnetic stem cell targeting to the retina using superparamagnetic iron oxide nanoparticles.

Yanai A, Häfeli UO, Metcalfe AL, Soema P, Addo L, Gregory-Evans CY, Po K, Shan X, Moritz OL, Gregory-Evans K. Yanai A, et al. Among authors: hafeli uo. Cell Transplant. 2012;21(6):1137-48. doi: 10.3727/096368911X627435. Epub 2012 Mar 8. Cell Transplant. 2012. PMID: 22405427 Free article.

10

Therapeutic drug monitoring in interstitial fluid: a feasibility study using a comprehensive panel of drugs.

Kiang TK, Schmitt V, Ensom MH, Chua B, Häfeli UO. Kiang TK, et al. Among authors: hafeli uo. J Pharm Sci. 2012 Dec;101(12):4642-52. doi: 10.1002/jps.23309. Epub 2012 Aug 31. J Pharm Sci. 2012. PMID: 22941939

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

118 results

Search Page